- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| LANSEN PHARMACEUTICAL Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 32,075 | +0,03 % | Deutlich höhere Dosis: Wegovy-Offensive: Novo Nordisk kontert Eli Lilly mit Mega-Dosis | © Foto: Christian Schultz/dpaNovo Nordisk geht in die Offensive: Mit einer deutlich höheren Wegovy-Dosis will der Konzern im boomenden Markt für Abnehmmedikamente verlorene Marktanteile zurückholen... ► Artikel lesen | |
| GILEAD SCIENCES | 118,00 | -0,46 % | Evotec sieht ca. 100 Mio USD Voraberlöse aus Tubulis-Kauf durch Gilead | DJ Evotec sieht ca. 100 Mio USD Voraberlöse aus Tubulis-Kauf durch Gilead
DOW JONES--Das Wirkstoffforschungsunternehmen Evotec rechnet infolge der Übernahme des deutschen Biotech-Unternehmens Tubulis... ► Artikel lesen | |
| ABBVIE | 177,50 | +0,06 % | Studie: Eierstockkrebs-Medikament von AbbVie zeigt 62,7 % Ansprechrate | ||
| ASTRAZENECA | 174,35 | +0,23 % | JPMORGAN stuft ASTRAZENECA auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca mit einem Kursziel von 16000 Pence auf "Overweight" belassen. Richard Vosser rechnet mit einer starken Umsatzentwicklung... ► Artikel lesen | |
| INNOCAN PHARMA | 3,910 | -2,98 % | Innocan Pharma Corporation: Innocan Pharma Announces Closing of Additional Debenture | The Debenture will bear interest at the rate of 10% per annum and matures at the earlier of: (i) 12 months from the date of issuance; and (ii) the completion of the Company's previously announced proposed... ► Artikel lesen | |
| MPH HEALTH CARE | 18,850 | +0,53 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
21.11.2025 / 12:01 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | -11,11 % | Digicann Ventures Inc.: Digicann Ventures Announces Resignation of Director | Vancouver, British Columbia--(Newsfile Corp. - April 8, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis... ► Artikel lesen | |
| INCYTE | 81,88 | -0,05 % | Adagene Inc.: Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte's TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC) | Phase 1 study of INCA33890 and muzastotug expected to begin in 2026 in 3L MSS CRC patients with and without liver metastases Study will be sponsored and conducted by Incyte; Adagene to provide clinical... ► Artikel lesen | |
| BAUSCH HEALTH | 4,538 | -5,06 % | Bausch Health Companies Posts Q4 Loss | OTTAWA (dpa-AFX) - Bausch Health Companies Inc. (BHC, BHC.TO) on Wednesday reported a net loss of $112 million for the fourth quarter, compared with a consolidated net income of $93 million... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,226 | +2,34 % | Organigram Global Inc.: Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), is pleased to announce that the shareholders of Organigram have overwhelmingly approved the resolution required to... ► Artikel lesen | |
| SINOPHARM | 2,250 | -0,35 % | SINOPHARM (01099): NOTICE OF BOARD MEETING | ||
| CSPC PHARMA | 0,998 | -0,63 % | CSPC PHARMA (01093): UPDATE ANNOUNCEMENT - CONNECTED TRANSACTION IN RELATION TO THE DISPOSAL OF 30.0704% EQUITY INTEREST IN THE TARGET COMPANY | ||
| TONIX PHARMACEUTICALS | 10,710 | +0,75 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and ... | Intranasal oxytocin blocks the release of calcitonin gene-related peptide (CGRP) in animal models and is the core technology of TNX-1900 for craniofacial pain conditions, including migraine and trigeminal... ► Artikel lesen | |
| NEWRON PHARMACEUTICALS | 16,550 | +3,12 % | BioNTech, Newron und Emyria: Biotech-Unternehmen rücken in den Fokus einer neuen Substanzdebatte | ||
| ORAMED PHARMACEUTICALS | 2,990 | -0,99 % | Lifeward Ltd.: Lifeward Successfully Closes on Strategic Partnership with Oramed | HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen |
LANSEN PHARMACEUTICAL HOLDINGS LTD gehört der Branche Pharma an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LANSEN PHARMACEUTICAL HOLDINGS LTD finden Sie auf Wallstreet Online.